162 related articles for article (PubMed ID: 36036113)
1. Effect of Helicobacter pylori on immunotherapy is gaining more attention.
Shi Y; Zheng H; Guo Z; Deng R; Yu W; Song Y; Ding S
Helicobacter; 2022 Oct; 27(5):e12925. PubMed ID: 36036113
[TBL] [Abstract][Full Text] [Related]
2. Influence of Helicobacter pylori infection on PD-1/PD-L1 blockade therapy needs more attention.
Shi Y; Zheng H; Wang M; Ding S
Helicobacter; 2022 Apr; 27(2):e12878. PubMed ID: 35112435
[TBL] [Abstract][Full Text] [Related]
3. States and hotspots in Helicobacter pylori research from 2002 to 2021: A bibliometric analysis.
Wang R; Huang S; Gan P; Pan X; Wang P; Zhong X; Lü M; Zhou X; Tang X
Helicobacter; 2023 Aug; 28(4):e12986. PubMed ID: 37133423
[TBL] [Abstract][Full Text] [Related]
4. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
[TBL] [Abstract][Full Text] [Related]
5. Bibliometric analysis of Helicobacter pylori resistance-from 2002 to 2022.
Li M; Gao N; Wang S; Guo Y; Liu Z
Helicobacter; 2023 Aug; 28(4):e12983. PubMed ID: 37102470
[TBL] [Abstract][Full Text] [Related]
6. Research trends on the relationship between Helicobacter pylori and microbiota: A bibliometric analysis.
Li Y; Ouyang Y; He C
Helicobacter; 2023 Dec; 28(6):e13021. PubMed ID: 37697432
[TBL] [Abstract][Full Text] [Related]
7. Immune-related adverse events: A bibliometric analysis.
Jiang ST; Liu YG; Zhang L; Sang XT; Xu YY; Lu X
Front Immunol; 2022; 13():1096806. PubMed ID: 36591239
[TBL] [Abstract][Full Text] [Related]
8. The most influential articles in Helicobacter pylori research: A bibliometric analysis.
Bang CS; Lee JJ; Baik GH
Helicobacter; 2019 Aug; 24(4):e12589. PubMed ID: 31033071
[TBL] [Abstract][Full Text] [Related]
9. Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study.
Cheng K; Zhang H; Guo Q; Zhai P; Zhou Y; Yang W; Wang Y; Lu Y; Shen Z; Wu H
Front Immunol; 2022; 13():975695. PubMed ID: 36148235
[TBL] [Abstract][Full Text] [Related]
10. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer.
Gao Y; Shi S; Ma W; Chen J; Cai Y; Ge L; Li L; Wu J; Tian J
Int Immunopharmacol; 2019 Jul; 72():374-384. PubMed ID: 31030093
[TBL] [Abstract][Full Text] [Related]
11. Research trends on anti-PD-1/PD-L1 immunotherapy for esophageal cancer: A bibliometric analysis.
Yang Y; Wang F
Front Oncol; 2022; 12():983892. PubMed ID: 36465399
[TBL] [Abstract][Full Text] [Related]
12. Trends in
Yu C; Qiu J; Xiong M; Ou C; Zeng M; Song H
Front Med (Lausanne); 2022; 9():1027534. PubMed ID: 36507534
[TBL] [Abstract][Full Text] [Related]
13. Global Trend on Machine Learning in
Eslami O; Nakhaie M; Rezaei Zadeh Rukerd M; Azimi M; Shahabi E; Honarmand A; Khazaneha M
Glob Health Epidemiol Genom; 2023; 2023():8856736. PubMed ID: 37600599
[TBL] [Abstract][Full Text] [Related]
14. The research status of immune checkpoint blockade by anti-CTLA4 and anti-PD1/PD-l1 antibodies in tumor immunotherapy in China: A bibliometrics study.
Zhao X; He L; Mao K; Chen D; Jiang H; Liu Z
Medicine (Baltimore); 2018 Apr; 97(15):e0276. PubMed ID: 29642147
[TBL] [Abstract][Full Text] [Related]
15. Update on the COVID-19 Vaccine Research Trends: A Bibliometric Analysis.
Xu Z; Qu H; Ren Y; Gong Z; Ri HJ; Zhang F; Chen X; Zhu W; Shao S; Chen X
Infect Drug Resist; 2021; 14():4237-4247. PubMed ID: 34703250
[TBL] [Abstract][Full Text] [Related]
16. Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors.
Che H; Xiong Q; Ma J; Chen S; Wu H; Xu H; Hou B
BMC Cancer; 2022 Aug; 22(1):904. PubMed ID: 35986342
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between
Yang S; Hao S; Ye H; Zhang X
Front Cell Infect Microbiol; 2024; 14():1353094. PubMed ID: 38357448
[TBL] [Abstract][Full Text] [Related]
18. Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer.
Zheng W; Wu Y; Wang Y; Cheng J; Shen W
Medicine (Baltimore); 2023 Jul; 102(27):e34228. PubMed ID: 37417594
[TBL] [Abstract][Full Text] [Related]
19. Research Trends on Clinical Helicobacter pylori Eradication: A Bibliometric Analysis from 1983 to 2020.
Ouyang Y; Zhu Z; Huang L; Zeng C; Zhang L; Wu WK; Lu N; Xie C
Helicobacter; 2021 Oct; 26(5):e12835. PubMed ID: 34258827
[TBL] [Abstract][Full Text] [Related]
20. Impact of
Noori M; Fayyaz F; Rezaei N
Immunotherapy; 2023 Jun; 15(9):657-667. PubMed ID: 37140002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
